Activation of α7‐nAChRs protects SH‐SY5Y cells from 1‐methyl‐4‐phenylpyridinium‐induced apoptotic cell death via ERK/p53 signaling pathway

S Xu, B Yang, T Tao, J Zhang, Y Liu… - Journal of Cellular …, 2019 - Wiley Online Library
Epidemiologic studies have shown a reduced risk of developing Parkinson's disease (PD)
among cigarette smokers. Nicotine, as a key component in tobacco products, is thought as a …

Cytarabine prevents neuronal damage by enhancing AMPK to stimulate PINK1/Parkin-involved mitophagy In Parkinson's disease model

L Li, Y Zhang, Z Chen, C Xu, Z Xu, H Pei… - European Journal of …, 2024 - Elsevier
Parkinson's disease (PD) is a common age-related neurodegenerative disorder, which may
be largely due to the mitochondrial dysfunction and impaired mitophagy. Thus, it is of great …

Valeriana officinalis counteracts rotenone effects on spreading depression in the rat brain in vivo and protects against rotenone cytotoxicity toward rat glioma C6 cells …

AP Amaral de Brito, IMS Galvão de Melo… - Frontiers in …, 2020 - frontiersin.org
Astrocytes can protect neurons against oxidative stress and excitability-dependent
disorders, such as epilepsy. Valeriana officinalis has been used as anticonvulsant and can …

Understanding the Potential of Genome Editing in Parkinson's Disease

D Arango, A Bittar, NP Esmeral, C Ocasión… - International Journal of …, 2021 - mdpi.com
CRISPR is a simple and cost-efficient gene-editing technique that has become increasingly
popular over the last decades. Various CRISPR/Cas-based applications have been …

Targeting Mitochondrial Complex I Deficiency in MPP+/MPTP-induced Parkinson's Disease Cell Culture and Mouse Models by Transducing Yeast NDI1 Gene

H Li, J Zhang, Y Shen, Y Ye, Q Jiang, L Chen… - Biological Procedures …, 2024 - Springer
Abstract Background MPTP (1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine), original found
in synthetic heroin, causes Parkinson's disease (PD) in human through its metabolite MPP+ …

[PDF][PDF] Nanobiosensors for early detection of neurodegenerative disease

P Fazlali, A Mahdian, MS Soheilifar… - Journal of Composites …, 2022 - academia.edu
Every year, tens of millions of individuals worldwide are affected by neurodegenerative
illnesses, which are defined by the inevitable annihilation of non-specific surroundings brain …

[HTML][HTML] Post‐inflammatory administration of N‐acetylcysteine reduces inflammation and alters receptor levels in a cellular model of Parkinson's disease

ZB Kaya, E Karakoc, PJ McLean, E Saka… - FASEB …, 2023 - ncbi.nlm.nih.gov
Parkinson's disease (PD) is a complex, multifactorial neurodegenerative disease with a
prevalence of 1% over the age of 55. Neuropathological hallmarks of PD include the loss of …

Gene therapy of yeast NDI1 on mitochondrial complex I dysfunction in rotenone-induced Parkinson's disease models in vitro and vivo

H Li, B Sun, Y Huang, J Zhang, X Xu, Y Shen… - Molecular …, 2022 - Springer
Purpose Parkinson's disease (PD) is the second most common neurodegenerative disease
without cure or effective treatment. This study explores whether the yeast internal NADH …

Bringing advanced therapies for Parkinson's disease to the clinic: the patient's perspective

S Mathur, J Stamford - Journal of Parkinson's Disease, 2021 - content.iospress.com
There is an urgent unmet need in the Parkinson's disease community—advanced therapies
to modify the inevitable decline that occurs in those affected by this progressive …

Research progress on intranasal treatment for Parkinson's disease

P Wen, C Ren - Neuroprotection, 2024 - Wiley Online Library
Parkinson's disease (PD) is the second most prevalent neurodegenerative disorder globally,
significantly affecting the quality of life of affected individuals. Systemic drug delivery to the …